Subscribe 600$/product give away!
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

BONJESTA- doxylamine succinate and pyridoxine hydrochloride tablet, extended release

Patient Information

See FDA-approved patient labeling (Patient Information)


Inform women to avoid engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery, while using BONJESTA until cleared to do so.

Inform women of the importance of not taking BONJESTA with alcohol or sedating medications, including other antihistamines (present in some cough and cold medications), opiates and sleep aids because somnolence could worsen leading to falls or other accidents.

Interference with urine drug screening

Inform women that use of BONJESTA may result in false positive urine drug screening for methadone, opiates and PCP.

BONJESTA is a registered trademark of Duchesnay Inc.

U.S. Patent Nos. 9,089,489, 7,560,122, 9,375,404 & 9,526,703.

Manufactured by:
Duchesnay Inc.
950 boul. Mich le-Bohec
Blainville, Qu bec
Canada J7C 5E2

Distributed by:
Duchesnay USA, Inc.
Bryn Mawr, PA, 19010
Tel: 1-855-722-7734
Fax: 1-888-588-8508

2018, Duchesnay Inc. All rights reserved.

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: